EPIVINF

We aim to gain a deeper understanding of how acute viral infections alter the epigenetic regulation of host factors that are critical for immune control and neurological health related to these infections. In particular, EPIVINF will address how acute viral infections impact epigenetic control of host proteins that drive virus-associated disease and/or are involved in the antiviral immune response and how such persistent, epigenetic marks are related to long-term disease evolution. EPIVINF will focus on two major human viral infections, HIV and SARS-CoV-2, both pathogens that affect millions of people around the world and which, despite well-known differences, share some intriguing features that demand further research. Project funded by the #HorizonEurope programme (GA 101057548).